Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2015

01-04-2015 | Article

Severity markers in severe leptospirosis: a cohort study

Authors: M. Mikulski, P. Boisier, F. Lacassin, M.-E. Soupé-Gilbert, C. Mauron, L. Bruyere-Ostells, D. Bonte, Y. Barguil, A.-C. Gourinat, M. Matsui, F. Vernel-Pauillac, C. Goarant

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2015

Login to get access

Abstract

We aimed to evaluate parameters for their value as severity markers in hospitalized leptospirosis patients. We recruited 47 informed adult consenting patients and assessed a number of clinical, hematological, biochemical, and biological variables. Patients were sorted according to severity based on fatality or the requirement of mechanical ventilation or dialysis; the parameters studied were compared between groups on inclusion and the next day. Beside septic shock presentation or a high severity score (Simplified Acute Physiology Score; SAPS II), increased lactate, total bilirubin, lipase, and AST/ALT ratio or a decreased cytokines IL-10/TNF-α ratio were all significantly associated with severity. The gene expression of the IL-1 receptor antagonist IL-1ra, IL-1α, and the long pentraxin PTX-3 were also transcribed at higher levels in most severe cases. Patients could rapidly improve or deteriorate, highlighting the need for a new assessment the next day. Our results add to the limited body of knowledge about severity markers in leptospirosis. They also suggest that patients should be reassessed the next day before being possibly discharged from the hospital. Further studies are needed in order to confirm relevant and reliable prognostic parameters in leptospirosis that would be helpful for the purpose of triage.
Appendix
Available only for authorised users
Literature
1.
go back to reference Abela-Ridder B, Sikkema R, Hartskeerl RA (2010) Estimating the burden of human leptospirosis. Int J Antimicrob Agents 36(Suppl 1):S5–S7. PubMed PMID: 20688484CrossRefPubMed Abela-Ridder B, Sikkema R, Hartskeerl RA (2010) Estimating the burden of human leptospirosis. Int J Antimicrob Agents 36(Suppl 1):S5–S7. PubMed PMID: 20688484CrossRefPubMed
2.
go back to reference McBride AJ, Athanazio DA, Reis MG, Ko AI (2005) Leptospirosis. Curr Opin Infect Dis 18(5):376–386. PubMed PMID: 16148523CrossRefPubMed McBride AJ, Athanazio DA, Reis MG, Ko AI (2005) Leptospirosis. Curr Opin Infect Dis 18(5):376–386. PubMed PMID: 16148523CrossRefPubMed
3.
go back to reference Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA et al (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757–771CrossRefPubMed Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA et al (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757–771CrossRefPubMed
4.
go back to reference Agampodi SB, Peacock SJ, Thevanesam V, Nugegoda DB, Smythe L, Thaipadungpanit J et al (2011) Leptospirosis outbreak in Sri Lanka in 2008: lessons for assessing the global burden of disease. Am J Trop Med Hyg 85(3):471–478. PubMed PMID: 21896807CrossRefPubMedCentralPubMed Agampodi SB, Peacock SJ, Thevanesam V, Nugegoda DB, Smythe L, Thaipadungpanit J et al (2011) Leptospirosis outbreak in Sri Lanka in 2008: lessons for assessing the global burden of disease. Am J Trop Med Hyg 85(3):471–478. PubMed PMID: 21896807CrossRefPubMedCentralPubMed
5.
go back to reference Amilasan AS, Ujiie M, Suzuki M, Salva E, Belo MCP, Koizumi N et al (2012) Outbreak of leptospirosis after flood, the Philippines, 2009. Emerg Infect Dis 18(1):91–94CrossRefPubMedCentralPubMed Amilasan AS, Ujiie M, Suzuki M, Salva E, Belo MCP, Koizumi N et al (2012) Outbreak of leptospirosis after flood, the Philippines, 2009. Emerg Infect Dis 18(1):91–94CrossRefPubMedCentralPubMed
6.
go back to reference Barcellos C, Sabroza PC (2001) The place behind the case: leptospirosis risks and associated environmental conditions in a flood-related outbreak in Rio de Janeiro. Cad Saude Publica 17(Suppl):59–67. PubMed PMID: 11426266PubMed Barcellos C, Sabroza PC (2001) The place behind the case: leptospirosis risks and associated environmental conditions in a flood-related outbreak in Rio de Janeiro. Cad Saude Publica 17(Suppl):59–67. PubMed PMID: 11426266PubMed
7.
go back to reference Cruz LS, Vargas R, Lopes AA (2009) Leptospirosis: a worldwide resurgent zoonosis and important cause of acute renal failure and death in developing nations. Ethn Dis 19(1 Suppl 1):37–41. PubMed PMID: 19484873 Cruz LS, Vargas R, Lopes AA (2009) Leptospirosis: a worldwide resurgent zoonosis and important cause of acute renal failure and death in developing nations. Ethn Dis 19(1 Suppl 1):37–41. PubMed PMID: 19484873
8.
go back to reference Goarant C, Laumond-Barny S, Perez J, Vernel-Pauillac F, Chanteau S, Guigon A (2009) Outbreak of leptospirosis in New Caledonia: diagnosis issues and burden of disease. Trop Med Int Health 14(8):926–929CrossRefPubMed Goarant C, Laumond-Barny S, Perez J, Vernel-Pauillac F, Chanteau S, Guigon A (2009) Outbreak of leptospirosis in New Caledonia: diagnosis issues and burden of disease. Trop Med Int Health 14(8):926–929CrossRefPubMed
9.
go back to reference Brown MG, Vickers IE, Salas RA, Smikle MF (2010) Leptospirosis in suspected cases of dengue in Jamaica, 2002–2007. Trop Doct 40(2):92–94. PubMed PMID: 20305103CrossRefPubMed Brown MG, Vickers IE, Salas RA, Smikle MF (2010) Leptospirosis in suspected cases of dengue in Jamaica, 2002–2007. Trop Doct 40(2):92–94. PubMed PMID: 20305103CrossRefPubMed
10.
go back to reference Ellis T, Imrie A, Katz AR, Effler PV (2008) Underrecognition of leptospirosis during a dengue fever outbreak in Hawaii, 2001–2002. Vector Borne Zoonotic Dis 8(4):541–547. PubMed PMID: 18447625CrossRefPubMedCentralPubMed Ellis T, Imrie A, Katz AR, Effler PV (2008) Underrecognition of leptospirosis during a dengue fever outbreak in Hawaii, 2001–2002. Vector Borne Zoonotic Dis 8(4):541–547. PubMed PMID: 18447625CrossRefPubMedCentralPubMed
11.
go back to reference LaRocque RC, Breiman RF, Ari MD, Morey RE, Janan FA, Hayes JM et al (2005) Leptospirosis during dengue outbreak, Bangladesh. Emerg Infect Dis 11(5):766–769. PubMed PMID: 15890136CrossRefPubMedCentralPubMed LaRocque RC, Breiman RF, Ari MD, Morey RE, Janan FA, Hayes JM et al (2005) Leptospirosis during dengue outbreak, Bangladesh. Emerg Infect Dis 11(5):766–769. PubMed PMID: 15890136CrossRefPubMedCentralPubMed
12.
go back to reference Vernel-Pauillac F, Goarant C (2010) Differential cytokine gene expression according to outcome in a hamster model of leptospirosis. PLoS Negl Trop Dis 4(1):e582. PubMed PMID: 20076757CrossRefPubMedCentralPubMed Vernel-Pauillac F, Goarant C (2010) Differential cytokine gene expression according to outcome in a hamster model of leptospirosis. PLoS Negl Trop Dis 4(1):e582. PubMed PMID: 20076757CrossRefPubMedCentralPubMed
13.
go back to reference Merien F, Portnoi D, Bourhy P, Charavay F, Berlioz-Arthaud A, Baranton G (2005) A rapid and quantitative method for the detection of Leptospira species in human leptospirosis. FEMS Microbiol Lett 249:139–147. PubMed PMID: 16006065CrossRefPubMed Merien F, Portnoi D, Bourhy P, Charavay F, Berlioz-Arthaud A, Baranton G (2005) A rapid and quantitative method for the detection of Leptospira species in human leptospirosis. FEMS Microbiol Lett 249:139–147. PubMed PMID: 16006065CrossRefPubMed
14.
go back to reference Tajiki MH, Nakama ASY, Salomão R (1997) The ratio of plasma levels of Il-10/TNF-alpha and its relationship to disease severity and survival in patients with leptospirosis. Braz J Infect Dis 1(3):138–141PubMed Tajiki MH, Nakama ASY, Salomão R (1997) The ratio of plasma levels of Il-10/TNF-alpha and its relationship to disease severity and survival in patients with leptospirosis. Braz J Infect Dis 1(3):138–141PubMed
15.
go back to reference Kyriakidis I, Samara P, Papa A (2011) Serum TNF-alpha, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil’s syndrome. Cytokine 54(2):117–120. PubMed PMID: 21316985CrossRefPubMed Kyriakidis I, Samara P, Papa A (2011) Serum TNF-alpha, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil’s syndrome. Cytokine 54(2):117–120. PubMed PMID: 21316985CrossRefPubMed
16.
go back to reference Chang ML, Yang CW, Chen JC, Ho YP, Pan MJ, Lin CH et al (2005) Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis. World J Gastroenterol 11(35):5553–5556. PubMed PMID: 16222754PubMedCentralPubMed Chang ML, Yang CW, Chen JC, Ho YP, Pan MJ, Lin CH et al (2005) Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis. World J Gastroenterol 11(35):5553–5556. PubMed PMID: 16222754PubMedCentralPubMed
17.
go back to reference Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J et al (1999) Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 29(6):1561–1563. PubMed PMID: 10585813CrossRefPubMed Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J et al (1999) Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 29(6):1561–1563. PubMed PMID: 10585813CrossRefPubMed
18.
go back to reference Vickery B, Flynn SA, Calder L, Freebairn RC (2006) Leptospirosis presenting to an intensive care unit in provincial New Zealand: a case series and review. Crit Care Resusc 8(3):192–199. PubMed PMID: 16930102PubMed Vickery B, Flynn SA, Calder L, Freebairn RC (2006) Leptospirosis presenting to an intensive care unit in provincial New Zealand: a case series and review. Crit Care Resusc 8(3):192–199. PubMed PMID: 16930102PubMed
19.
go back to reference Martínez García MA, de Diego Damiá A, Menéndez Villanueva R, López Hontagas JL (2000) Pulmonary involvement in leptospirosis. Eur J Clin Microbiol Infect Dis 19(6):471–474. PubMed PMID: 10947225CrossRefPubMed Martínez García MA, de Diego Damiá A, Menéndez Villanueva R, López Hontagas JL (2000) Pulmonary involvement in leptospirosis. Eur J Clin Microbiol Infect Dis 19(6):471–474. PubMed PMID: 10947225CrossRefPubMed
20.
go back to reference Reis EAG, Hagan JE, Ribeiro GS, Teixeira-Carvalho A, Martins-Filho OA, Montgomery RR et al (2013) Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS Negl Trop Dis 7(9):e2457CrossRefPubMedCentralPubMed Reis EAG, Hagan JE, Ribeiro GS, Teixeira-Carvalho A, Martins-Filho OA, Montgomery RR et al (2013) Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS Negl Trop Dis 7(9):e2457CrossRefPubMedCentralPubMed
21.
go back to reference Herrmann-Storck C, Saint-Louis M, Foucand T, Lamaury I, Deloumeaux J, Baranton G et al (2010) Severe leptospirosis in hospitalized patients, Guadeloupe. Emerg Infect Dis 16(2):331–334. PubMed PMID: 20113574CrossRefPubMedCentralPubMed Herrmann-Storck C, Saint-Louis M, Foucand T, Lamaury I, Deloumeaux J, Baranton G et al (2010) Severe leptospirosis in hospitalized patients, Guadeloupe. Emerg Infect Dis 16(2):331–334. PubMed PMID: 20113574CrossRefPubMedCentralPubMed
22.
go back to reference Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D (2004) Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med Wkly 134(23–24):347–352. PubMed PMID: 15318284PubMed Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D (2004) Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med Wkly 134(23–24):347–352. PubMed PMID: 15318284PubMed
23.
go back to reference Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, van der Poll T et al (2009) Soluble ST2 levels are associated with bleeding in patients with severe leptospirosis. PLoS Negl Trop Dis 3(6):e453. PubMed PMID: 19488407CrossRefPubMedCentralPubMed Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, van der Poll T et al (2009) Soluble ST2 levels are associated with bleeding in patients with severe leptospirosis. PLoS Negl Trop Dis 3(6):e453. PubMed PMID: 19488407CrossRefPubMedCentralPubMed
24.
go back to reference Estavoyer JM, Chirouze C, Faucher JF, Floret N, Couetdic G, Leroy J et al (2013) Leptospirosis in Franche-Comté (FRANCE): clinical, biological, and therapeutic data. Med Mal Infect 43:379–385CrossRefPubMed Estavoyer JM, Chirouze C, Faucher JF, Floret N, Couetdic G, Leroy J et al (2013) Leptospirosis in Franche-Comté (FRANCE): clinical, biological, and therapeutic data. Med Mal Infect 43:379–385CrossRefPubMed
25.
go back to reference Tubiana S, Mikulski M, Becam J, Lacassin F, Lefèvre P, Gourinat A-C et al (2013) Risk factors and predictors of severe leptospirosis in New Caledonia. PLoS Negl Trop Dis 7(1):e1991. PubMed PMID: 23326614CrossRefPubMedCentralPubMed Tubiana S, Mikulski M, Becam J, Lacassin F, Lefèvre P, Gourinat A-C et al (2013) Risk factors and predictors of severe leptospirosis in New Caledonia. PLoS Negl Trop Dis 7(1):e1991. PubMed PMID: 23326614CrossRefPubMedCentralPubMed
26.
go back to reference Panaphut T, Domrongkitchaiporn S, Thinkamrop B (2002) Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 6(1):52–59. PubMed PMID: 12044303CrossRefPubMed Panaphut T, Domrongkitchaiporn S, Thinkamrop B (2002) Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 6(1):52–59. PubMed PMID: 12044303CrossRefPubMed
27.
go back to reference Marotto PC, Ko AI, Murta-Nascimento C, Seguro AC, Prado RR, Barbosa MC et al (2010) Early identification of leptospirosis-associated pulmonary hemorrhage syndrome by use of a validated prediction model. J Infect 60(3):218–223. PubMed PMID: 20026189CrossRefPubMedCentralPubMed Marotto PC, Ko AI, Murta-Nascimento C, Seguro AC, Prado RR, Barbosa MC et al (2010) Early identification of leptospirosis-associated pulmonary hemorrhage syndrome by use of a validated prediction model. J Infect 60(3):218–223. PubMed PMID: 20026189CrossRefPubMedCentralPubMed
28.
go back to reference Berlioz-Arthaud A, Mérien F, Baranton G (2007) Laboratory based human leptospirosis surveillance in New Caledonia (2001–2005). Bull Soc Pathol Exot 100(2):133–138. PubMed PMID: 17727039PubMed Berlioz-Arthaud A, Mérien F, Baranton G (2007) Laboratory based human leptospirosis surveillance in New Caledonia (2001–2005). Bull Soc Pathol Exot 100(2):133–138. PubMed PMID: 17727039PubMed
29.
go back to reference Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S, Jarrige B, Daijardin JB (1997) Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 25(3):720–724. PubMed PMID: 9314467CrossRefPubMed Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S, Jarrige B, Daijardin JB (1997) Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 25(3):720–724. PubMed PMID: 9314467CrossRefPubMed
30.
go back to reference Ko AI, Galvão Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW (1999) Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354(9181):820–825. PubMed PMID: 10485724CrossRefPubMed Ko AI, Galvão Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW (1999) Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354(9181):820–825. PubMed PMID: 10485724CrossRefPubMed
31.
go back to reference Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC (1999) Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 61(4):630–634. PubMed PMID: 10548299PubMed Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC (1999) Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 61(4):630–634. PubMed PMID: 10548299PubMed
32.
go back to reference Brett-Major DM, Coldren R (2012) Antibiotics for leptospirosis. Cochrane Database Syst Rev 2:CD008264. PubMed PMID: 22336839PubMed Brett-Major DM, Coldren R (2012) Antibiotics for leptospirosis. Cochrane Database Syst Rev 2:CD008264. PubMed PMID: 22336839PubMed
33.
go back to reference Abgueguen P, Delbos V, Blanvillain J, Chennebault JM, Cottin J, Fanello S (2008) Clinical aspects and prognostic factors of leptospirosis in adults. Retrospective study in France. J Infect 57(3):171–178. PubMed PMID: 18656263CrossRefPubMed Abgueguen P, Delbos V, Blanvillain J, Chennebault JM, Cottin J, Fanello S (2008) Clinical aspects and prognostic factors of leptospirosis in adults. Retrospective study in France. J Infect 57(3):171–178. PubMed PMID: 18656263CrossRefPubMed
34.
go back to reference Wagenaar JF, Goris MG, Gasem MH, Isbandrio B, Moalli F, Mantovani A et al (2009) Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect 58(6):425–432. PubMed PMID: 19443038CrossRefPubMed Wagenaar JF, Goris MG, Gasem MH, Isbandrio B, Moalli F, Mantovani A et al (2009) Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect 58(6):425–432. PubMed PMID: 19443038CrossRefPubMed
35.
go back to reference Doudier B, Garcia S, Quennee V, Jarno P, Brouqui P (2006) Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect 12(4):299–300. PubMed PMID: 16524404CrossRefPubMed Doudier B, Garcia S, Quennee V, Jarno P, Brouqui P (2006) Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect 12(4):299–300. PubMed PMID: 16524404CrossRefPubMed
36.
go back to reference Wagenaar JF, Goris MG, Partiningrum DL, Isbandrio B, Hartskeerl RA, Brandjes DP et al (2010) Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health 15(2):152–159. PubMed PMID: 20002620CrossRefPubMed Wagenaar JF, Goris MG, Partiningrum DL, Isbandrio B, Hartskeerl RA, Brandjes DP et al (2010) Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health 15(2):152–159. PubMed PMID: 20002620CrossRefPubMed
37.
go back to reference Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA et al (2004) Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32(8):1637–1642. PubMed PMID: 15286537CrossRefPubMed Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA et al (2004) Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32(8):1637–1642. PubMed PMID: 15286537CrossRefPubMed
38.
go back to reference Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE et al (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164(3):396–402. PubMed PMID: 11500339CrossRefPubMed Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE et al (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164(3):396–402. PubMed PMID: 11500339CrossRefPubMed
39.
go back to reference Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270(24):2957–2963. PubMed PMID: 8254858CrossRefPubMed Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270(24):2957–2963. PubMed PMID: 8254858CrossRefPubMed
40.
go back to reference Tajiki H, Salomão R (1996) Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 23:1177–1178CrossRefPubMed Tajiki H, Salomão R (1996) Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 23:1177–1178CrossRefPubMed
41.
go back to reference Matsui M, Rouleau V, Bruyère-Ostells L, Goarant C (2011) Gene expression profiles of immune mediators and histopathological findings in animal models of leptospirosis: comparison between susceptible hamsters and resistant mice. Infect Immun 79(11):4480–4492. PubMed PMID: 21844232CrossRefPubMedCentralPubMed Matsui M, Rouleau V, Bruyère-Ostells L, Goarant C (2011) Gene expression profiles of immune mediators and histopathological findings in animal models of leptospirosis: comparison between susceptible hamsters and resistant mice. Infect Immun 79(11):4480–4492. PubMed PMID: 21844232CrossRefPubMedCentralPubMed
42.
go back to reference Lauw FN, Pajkrt D, Hack CE, Kurimoto M, van Deventer SJ, van der Poll T (2000) Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 165(5):2783–2789. PubMed PMID: 10946310CrossRefPubMed Lauw FN, Pajkrt D, Hack CE, Kurimoto M, van Deventer SJ, van der Poll T (2000) Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 165(5):2783–2789. PubMed PMID: 10946310CrossRefPubMed
43.
go back to reference te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 76(7):1392–1397. PubMed PMID: 2119829 te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 76(7):1392–1397. PubMed PMID: 2119829
44.
go back to reference Wu HP, Wu CL, Chen CK, Chung K, Tseng JC, Liu YC et al (2008) The interleukin-4 expression in patients with severe sepsis. J Crit Care 23(4):519–524. PubMed PMID: 19056016CrossRefPubMed Wu HP, Wu CL, Chen CK, Chung K, Tseng JC, Liu YC et al (2008) The interleukin-4 expression in patients with severe sepsis. J Crit Care 23(4):519–524. PubMed PMID: 19056016CrossRefPubMed
45.
go back to reference Athanazio DA, Santos CS, Santos AC, McBride FW, Reis MG (2008) Experimental infection in tumor necrosis factor alpha receptor, interferon gamma and interleukin 4 deficient mice by pathogenic Leptospira interrogans. Acta Trop 105(1):95–98. PubMed PMID: 17991451CrossRefPubMed Athanazio DA, Santos CS, Santos AC, McBride FW, Reis MG (2008) Experimental infection in tumor necrosis factor alpha receptor, interferon gamma and interleukin 4 deficient mice by pathogenic Leptospira interrogans. Acta Trop 105(1):95–98. PubMed PMID: 17991451CrossRefPubMed
46.
go back to reference Friedland JS, Warrell DA (1991) The Jarisch–Herxheimer reaction in leptospirosis: possible pathogenesis and review. Rev Infect Dis 13(2):207–210. PubMed PMID: 2041950CrossRefPubMed Friedland JS, Warrell DA (1991) The Jarisch–Herxheimer reaction in leptospirosis: possible pathogenesis and review. Rev Infect Dis 13(2):207–210. PubMed PMID: 2041950CrossRefPubMed
47.
Metadata
Title
Severity markers in severe leptospirosis: a cohort study
Authors
M. Mikulski
P. Boisier
F. Lacassin
M.-E. Soupé-Gilbert
C. Mauron
L. Bruyere-Ostells
D. Bonte
Y. Barguil
A.-C. Gourinat
M. Matsui
F. Vernel-Pauillac
C. Goarant
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2015
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2275-8

Other articles of this Issue 4/2015

European Journal of Clinical Microbiology & Infectious Diseases 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.